Sauer, B. et al, 1988, PNAS, vol. 85, pp. 5166-5170. |
Niwa et al., "Efficient Selection for High-Expression Transfectants with a Novel Eukaryotic Vector," Gene, 108, pp. 193-200 (1991). |
Engelhardt et al., "Direct Gene Transfer of Human CFTR Into Human Bronchial Epithelia of Xenografts with El-Deleted Adenoviruses," Nature Genetics, vol. 4, pp. 27-34 (May 1993). |
Saito et al., "Adenovirus Vector," the 41st General Meeting: The Society of Japanese Virologists (1993). |
Kanegae et al., "Adenovirus Vector and Gene Therapy," Experimental Medicine, vol. 12, No. 3 (1994). |
Kanegae et al., Experimental Medicine Supplemental Volume, Biomanual Series 4, pp. 43-58 (1994). |
Gu et al., "Deletion of DNA Polymerase . . . Targeting," Science, vol. 265, Jul. 1, 1994, pp. 103-106. |
Anton et al., "Site Specific Recombinaiton Mediated . . . Expression," Journal of Virology, Aug. 1995, pp. 4600-4606. |
First Annual Meeting 1995 Japanese Society of Gene Therapy, Program and Abstract, May 21, 1995, Kanagae et al, "Application of Cre/LoxP System to Adenovirus Vector". |
Kanegae et al., "Efficient Gene Activation . . . Recombinase," Nucleic Acids Research, vol. 23, No. 19, pp. 3816-3821 (1995). |
Bergemann et al., "Excision of Specific DNA . . . Recombination, " Nucleic Acids Research, vol. 23, No. 21, pp. 4451-4456 (1995). |
The 43rd Annual Meeting of the Society of Japanese Virologists, (Sep. 29, 1995), 2016, p. 126. |
The Second Brain Tumor Gene Therapy Meeting, Feb. 3 and 4, 1995, "Adenovirus Vector". |
Engelhardt et al, "Ablation of E2A in recombinant adenoviruses improvesd transgene persistence . . . ," Proc. Natl. Acad. Sci., vol. 91, pp. 6196-6200, Jun. 1994. |
Yang et al, "Inactivation of E2A in recombinant adenoviruses improves the prospects for gene therapy in cystic fibrosis," Nature Genetics, vol. 7, pp. 362-369, Jul. 1994. |
Gorziglia et al, "Elimination of both E1 and E2a from Adenovirus Vectors Further Improves Prospects for In Vivo Human Gene Therapy," J. Virology, vol. 70, No. 6, pp. 4173-4178, Jun. 1996. |